Standard BioTools Inc. Common Stock, Value, Issued
Standard BioTools Inc. (LAB) had Common Stock, Value, Issued of $410.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-05
- 2026-06-30: Common Stock, Value, Issued $410.00K.
- 2026-03-31: Common Stock, Value, Issued $408.00K.
- 2025-12-31: Common Stock, Value, Issued $404.00K.
- 2025-09-30: Common Stock, Value, Issued $401.00K.
| Period end | Common Stock, Value, Issued |
|---|---|
| 2026-06-30 | $410.00K 10-Q · filed 2026-08-05 |
| 2026-03-31 | $408.00K 10-Q · filed 2026-05-06 |
| 2025-12-31 | $404.00K 10-Q · filed 2026-08-05 |
| 2025-09-30 | $401.00K 10-Q · filed 2025-11-04 |
| 2025-06-30 | $400.00K 10-Q · filed 2025-08-15 |
| 2025-03-31 | $397.00K 10-Q · filed 2025-05-06 |
| 2024-12-31 | $396.00K 10-K · filed 2026-03-16 |
| 2024-09-30 | $390.00K 10-Q · filed 2024-11-06 |
| 2024-06-30 | $389.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $387.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $83.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | $82.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $81.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $80.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $80.00K 10-K · filed 2024-03-01 |
| 2022-09-30 | $79.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $79.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $77.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $77.00K 10-K · filed 2023-03-14 |
| 2021-09-30 | $76.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $76.00K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $75.00K 10-Q · filed 2021-05-07 |
| 2020-12-31 | $75.00K 10-K · filed 2022-03-08 |
| 2020-09-30 | $74.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $71.00K 10-Q · filed 2020-08-07 |
| 2020-03-31 | $71.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $70.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | $70.00K 10-Q · filed 2019-11-08 |
| 2019-06-30 | $69.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $69.00K 10-Q · filed 2019-05-07 |
| 2018-12-31 | $49.00K 10-K · filed 2020-02-27 |
| 2018-09-30 | $39.00K 10-Q · filed 2018-11-06 |
| 2018-06-30 | $39.00K 10-Q · filed 2018-08-08 |
| 2018-03-31 | $39.00K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $39.00K 10-K · filed 2019-03-18 |
| 2017-09-30 | $39.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $29.00K 10-Q · filed 2017-08-08 |
| 2017-03-31 | $29.00K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $29.00K 10-K · filed 2018-03-08 |
| 2016-09-30 | $29.00K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $29.00K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $29.00K 10-Q · filed 2016-05-09 |
| 2015-12-31 | $29.00K 10-K · filed 2017-03-03 |
| 2015-09-30 | $29.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $29.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $29.00K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $28.00K 10-K · filed 2016-02-29 |
| 2014-09-30 | $28.00K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $28.00K 10-Q · filed 2014-08-04 |
| 2014-03-31 | $28.00K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $26.00K 10-K · filed 2015-02-26 |
| 2013-09-30 | $26.00K 10-Q · filed 2013-11-07 |
| 2013-06-30 | $25.00K 10-Q · filed 2013-08-07 |
| 2013-03-31 | $25.00K 10-Q · filed 2013-05-09 |
| 2012-12-31 | $25.00K 10-K · filed 2014-03-12 |
| 2012-09-30 | $25.00K 10-Q · filed 2012-11-09 |
| 2012-06-30 | $21.00K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $20.00K 10-Q · filed 2012-05-15 |
| 2011-12-31 | $20.00K 10-K · filed 2013-03-12 |
| 2011-09-30 | $20.00K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $20.00K 10-Q · filed 2011-08-09 |
| 2010-12-31 | $2.00K 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |